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What are the most important predictive factors for 
clinically relevant posthepatectomy liver failure after 
right hepatectomy for hepatocellular carcinoma?
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1Department of Surgery, Yonsei University College of Medicine, Seoul, Korea
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INTRODUCTION
Liver resection remains the mainstay of treatment for 
hepa to cellular carcinoma (HCC). Recent advances in surgical 
techniques and instrumentations have greatly improved liver 
surgery outcomes [1,2]. However, the risk of posthepatectomy 
liver failure (PHLF) remains substantial after major hepatectomy 
[3] with a considerable fatal outcome rate [4]. Thus, a proper 
preoperative evaluation and identification of patients at risk for 
PHLF is of paramount importance.
Consequently, defining oncologic resections to prevent 
PHLF warrants a thorough assessment of future liver remnant 
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Purpose: The risk of posthepatectomy liver failure (PHLF) after right hepatectomy remains substantial. Additional 
parameters such as computed tomography volumetry, liver stiffness measurement by FibroScan, indocyanine green 
retention rate at 15 minutes, and platelet count used to properly assess future liver remnant volume quality and quantity 
are of the utmost importance. Thus, we compared the usefulness of these modalities for predicting PHLF among patients 
with hepatocellular carcinoma after right hepatectomy.
Methods: We retrospectively reviewed patients who underwent right hepatectomy for hepatocellular carcinoma between 
2007 and 2013. PHLF was determined according to International Study Group of Liver Surgery consensus definition and 
severity grading. Grades B and C were defined as clinically relevant posthepatectomy liver failure (CRPHLF). The results 
were internally validated using a cohort of 97 patients.
Results: Among the 90 included patients, 15 (16.7%) had CRPHLF. Multivariate analysis confirmed that platelet count < 
140 (109/L) (hazard ratio [HR], 24.231; 95% confidence interval [CI], 3.623–161.693; P = 0.001) and remnant liver volume-to-
body weight (RVL/BW) ratio < 0.55 (HR, 25.600; 95% CI, 4.185–156.590; P < 0.001) were independent predictors of CRPHLF. 
Among the 12 patients with a platelet count < 140 (109/L) and RLV/BW ratio < 0.55, 9 (75%) had CRPHLF. Likewise, 5 
of 38 (13.2%) with only one risk factor developed CRPHL versus 1 of 40 (2.5%) with no risk factors. These findings were 
confirmed by the validation cohort.
Conclusion: RLV/BW ratio and platelet count are more important than the conventional RLV/TFLV, indocyanine green 
retention rate at 15 minutes, and liver stiffness measurement in the preoperative risk assessment for CRPHLF.
[Ann Surg Treat Res 2020;98(2):62-71]
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(FLR) quality and quantity [5]. This is particularly relevant 
among patients who will undergo right hepatectomy because 
of the relatively small FLR in such cases. It was found that the 
remnant liver volume-to-body weight ratio (RLV/BWR) was 
more specific than the remnant liver volume-to-total functional 
liver volume (RLV/TFLV) ratio in assessing FLR following major 
hepatectomy in cirrhotic and noncirrhotic patients [6,7]. In 
addition, various quantitative and qualitative tests to assess 
liver function such as indocyanine green (ICG) [8-11], platelet 
count determination [12], and liver stiffness measurement 
using a FibroScan [13] are presently being utilized as part of 
the standard protocol prior to liver resection. The clinical 
application of these modalities for identifying patients at risk of 
PHLF and selecting patients who will most likely benefit from 
upfront curative hepatic resection or portal vein embolization 
(PVE) prior to resection deserves consideration.
However, the standardization of which among these 
sophisticated methods should be used preoperatively varies 
among centers. Up to date, it is still unclear which among 
these preoperative parameters play the most important role 
in determining PHLF. This study was conducted to compare 
the usefulness of CT volumetry using the conventional RLV/
TFLV and RLV/BW, ICG, liver stiffness measurement using 
a Fibroscan, and platelet count for predicting PHLF among 
patients with HCC after right hepatectomy according to the 
International Study Group of Liver Surgery (ISGLS) definition 
of PHLF. Using these modalities, we hope to identify patients 
at greatest and lowest risk for PHLF thereby identifying 
patients who might benefit from right hepatectomy or volume-
preserving right hepatectomy or PVE.
METHODS
Study design
Here we retrospectively reviewed the cases of all patients 
who underwent right hepatectomy for HCC between 2007 and 
2013. We only included those patients for whom preoperative 
FibroScan, CT volumetry, ICG retention rate at 15 minutes (ICG 
R15), complete blood count with differentials, and preoperative 
and postoperative liver function test data were available. 
Exclusion criteria were incomplete imaging and liver function 
test results and a lack of data to identify PHLF.
A cohort of patients who underwent right hepatectomy for 
HCC in the same period with incomplete laboratory results for 
ICG R 15% and liver stiffness measurement was retrospectively 
reviewed and formed the validation cohort of this study. The 
study protocol was approved by the Institutional Review Board 
(approval number 4-2018-0974), and the need for written 
informed consent was waived because of the retrospective 
nature of the study.
Data collection
The data were collected prospectively from the hospital’s 
electronic medical records database. The patients’ demographic 
characteristics, clinical presentations, preoperative comor-
bidities, perioperative outcomes, imaging studies, and labo-
ratory results were reviewed and analyzed. The imaging 
and laboratory studies were obtained within 1 month prior 
to surgery, and the most recent preoperative laboratory 
results were recorded. The postoperative complications were 
categorized according to Clavien-Dindo classification [14].
There were 4 surgeons performing liver resections during 
this period. The decision to perform the right hepatectomy was 
determined according to the patients’ general health condition, 
extent of tumor involvement, liver function (Child A), portal 
hypertension (presence of splenomegaly or esophageal varices), 
and liver volume. Generally, a right hepatectomy was performed 
in patients whose left liver volume was ≥30% of the total liver 
volume (TLV), Child A, and no signs of portal hypertension. 
Patients with <30% FLR usually underwent PVE or volume-
preserving right hepatectomy. Moreover, patients with hepatitis 
B or C virus infection were treated preoperatively.
Right hepatectomy
The abdomen was accessed using a right subcostal incision 
with midline extension to the xiphoid. After liver mobilization, 
the hanging method was utilized. The right hepatic artery 
and right portal vein were individually then ligated and 
transected and the right hepatic duct was left divided during 
the parenchymal transection. The parenchymal transection 
followed the intrahepatic course of the middle hepatic 
vein using the Cavitron Ultrasonic Surgical Aspirator. After 
hemo stasis was ensured, 2 drains were placed at the right 
subdiaphragmatic area and the abdomen was closed. The 
Pringle maneuver was not used in any case.
CT volumetry
TLV, total right liver volume, and tumor volume were 
measured manually by delineating the liver contour on every 
cut with a 3-mm slice thickness. The total surface area was 
then measured on each imaging cut and as well as the distance 
between slices for the volume calculation. The RLV to total 
functional liver volume (RLV/TFLV) and RLV to body weight 
(RLV/BW) ratios were calculated using the following formulas:
TFLV (cm3) = TLV - total tumor volume
RLV (cm3) = TLV - right liver volume
RLV/TFLV (%) = RLV (cm3) /TFLV (cm3) × 100
RLV/BW (%) = RLV (cm3) /actual body weight (g) × 100
For patients who underwent PVE, the liver volume after the 
PVE was measured and was used in the analysis. Only one 
surgeon prospectively reviewed and measured the liver volume 
in this cohort using the Voxelplus (Mevisys Co. Ltd., Daejeon, 
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Table 1. Clinical characteristics of patients in the primary study cohort and validation cohorts who underwent right 
hepatectomy for hepatocellular carcinoma
Variable Study cohort (n = 90) Validation cohort (n = 97) P-value
Age (yr) 55.6 ± 10.83 57.7 ± 10.38 0.169
Sex
    Male 78 (86.6) 73 (75.3) 0.063
    Female 12 (13.3) 24 (24.7)
Background liver disease
    HBV 77 (86.5) 72 (74.0) 0.102
    HCV 4 (4.5) 7 (7.2)
    Alcoholic liver cirrhosis 1 (1.1) 4 (4.1)
    Other 7 (7.8) 14 (14.4)
Laboratory findings
    Hemoglobin (g/dL) 14.2 ± 1.55 13.6 ± 1.8
    Platelet count (109/L) 175 ± 63.35 174 ± 70.11 0.935
    Albumin (g/dL) 4.3 ± 0.41  4.2 ± 0.45 0.647
    AST (IU/L) 35.7 ± 16.69
    ALT (IU/L) 37.3 ± 25.14
    Total bilirubin (mg/dL) 0.7 ± 0.23 0.673 ± 0.23 0.791
    INR 0.99 ± 0.07 1.00 ± 0.09 0.873
    α-FP (ng/mL) 3,503.3 ± 12,880.7 2,016.5 ± 9,844.1 0.377
    PIVKA-II (mAU/mL) 575 ± 1,965.4 1,291.5 ± 7,691.3 0.399
Liver function status
    ICG R15 (%) 9.2 ± 4.30 - -
    Liver stiffness on FibroScan (kPA) 12.4 ± 8.20 - -
    Child-Pugh score (%) A (100) A (100) 1.000
    MELD score 6.8 ± 0.89 6.9 ± 0.79 0.296
RLV status
    RLV/TFLV (%) 39.3 ± 10.71 40.4 ± 17.1 0.618
    RLV/BW 0.69 ± 0.24 0.68 ± 0.28 0.876
Tumor size (cm) 4.4 ± 2.1
Liver cirrhosis 
    No 24 (26.7) 60 (61.9) <0.001
    Yes 66 (73.3) 37 (38.1)
TACE 10 (11.1) 9 (9.3) 0.679
PVE 1 (1.1) 2 (2.1) 0.605
CCRT 8 (8.9) 5 (5.2) 0.316
Operative time (min) 269.4 ± 94.7 279.4 ± 742.9 0.529
Blood loss (mL) 594.3 ± 471.3 697.3 ± 120.8 0.263
Postoperative complicationsa) 45 (49.9) 51 (52.6)
    I 12 (13.3) 22 (22) 0.484
    II 18 (20.0) 18 (18.6)
    III 11 (12.2) 10 (10.3)
    IV 1 (1.1) 0 (0)
    V 3 (3.3) 1 (1)
Posthepatectomy liver failure (%) 24 (26.6) 30 (31.9) 0.913
    Grade A 9 (10.0) 10 (10.3)
    Grade B 11 (12.2) 15 (15.5)
    Grade C 4 (4.4) 5 (5.2)
Postoperative mortality (%) 3 (3.3) 1 (1.0)
Values are presented as mean ± standard deviation or number (%).
INR, international normalized ratio; PIVKA, protein induced by vitamin K absence/antagonist; ICG R15, indocyanine green retention 
rate at 15 minutes; MELD, model for end-stage liver disease; RLV, remnant liver volume; TFLV, total functional liver volume; BW, body 
weight; TACE, transarterial chemoembolization; PVE, portal vein embolization; CCRT, concurrent chemoradiotherapy.
a)Postoperative complication was assessed by Clavien-Dindo classification.
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ICG R15
For the ICG R15 test, ICG 0.5 mg/kg was administered through 
a peripheral vein and measured using pulse dye densitometry. 
The ICG R15 and plasma disappearance rate (ICG-k per minute) 
were recorded and calculated.
Liver stiffness
Liver stiffness in the right lobe of the liver was measured 
using a FibroScan (Echosens North America Inc., Waltham, MA, 
USA). A sonographic evaluation was used to properly identify 
the free-tumor liver parenchyma. Ten measurements were 
performed in all patients and the success rate was calculated 
as the number of validated measurements divided by the total 
number of measurements. For each patient, the liver stiffness 
values were accepted only if the success rate was at least 60%. 
The results are expressed in kilopascals (kPa). Liver stiffness 
was assessed by only one dedicated radiologist during this 
period.
Primary outcome
PHLF was determined according to the ISGLS consensus defi-
nition and severity grading [15]. Briefly, PHLF is characterized 
by increase in prothrombin time-international normalized 
ratio (PT-INR) and hyperbilibirubinemia (according to the 
normal cutoff levels defined by the local laboratory) on or after 
postoperative day 5. If PT-INR or serum bilirubin is increased 
preoperatively, PHLF is defined by an increasing PT-INR and 
serum bilirubin level on or before postoperative day 5 (compared 
Table 2. Comparisons of clinicopathologic variables between the groups with or without CRPHLF after right hepatectomy
Variable CRPHLF (n = 15) No CRPHLF (n = 75) P-value
Age (yr) 55 ± 10.23 56 ± 11.01 0.452
Sex
    Male 14 (93.3) 64 (85.3) 0.682
    Female 1 (6.7) 11 (14.7)
Body mass index (kg/m2) 23.3 ± 2.41 23.4 ± 3.2 0.383
Background liver disease 0.357
    HBV 13 (86.7) 64 (86.5)
    HCV 2 (13.3) 2 (2.7)
    Others 0 (0) 9 (10.8)
Platelet count (109/L) 126.3 ± 34.5 184.8 ± 63.4 <0.001
Albumin (g/dL) 4.30 ± 0.47 4.31 ± 0.40 0.302
AST (IU/L) 42.4 ± 23.01 34.35 ± 14.96 0.088
ALT (IU/L) 48.0 ± 40.52 35.16 ± 20.53 0.159
Total bilirubin (mg/dL) 0.78 ± 0.24 0.66 ± 0.22 0.053
PT-INR 1.02 ± 0.08 0.99 ± 0.07 0.266
ICG R15 (%) 10.51 ± 5.19 8.90 ± 4.08 0.188
Liver stiffness by FibroScan (kPa) 15.0 ± 7.88 11.9 ± 8.21 0.025
MELD score 7 ± 1.03 7 ± 0.87 0.298
RLV/TFLV (%) 31.8 ± 6.42 40.8 ± 10.82 0.003
RLV/BW 0.50 ± 0.11 0.72 ± 0.24 0.001
Operative time (min) 257 ± 49.56 271 ± 101.45 0.471
Blood loss (mL) 700 ± 528.47 573 ± 456.67 0.115
Preoperative TACE
    No 66 (82.5) 14 (93.3) 0.549
    Yes 9 (12) 1 (6.7)
Preoperative CCRT
    No 68 (82.9) 14 (93.3) 0.740
    Yes 7 (9.3) 1 (6.7)
Blood transfusion 
    No 13 (86.7) 67 (89.3) 0.764
    Yes 2 (13.3) 8 (10.7)
Length of hospital stay (day) 12.7 ± 5.2 23.7 ± 14.3 <0.001
Values are presented as mean ± standard deviation or number (%).
CRPHLF, clinically relevant posthepatectomy liver failure; PT-INR, prothrombin time-international normalized ratio; ICG R15, 
indocyanine green retention rate at 15 minutes; RLV, remnant liver volume; TFLV, total functional liver volume; BW, body weight; 
TACE, transarterial chemoembolization; CCRT, concurrent chemoradiotherapy.
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with the values of the previous day). Patients with abnormal 
laboratory parameters not requiring a change in clinical 
management were categorized as grade A. However, patients 
who required further clinical management but did not need 
invasive treatment and patients who needed invasive treatment 
were categorized as grades B and C, respectively. In this study, 
grade A was defined as non-clinically relevant PHLF (CRPHLF), 
whereas grade B and C were defined as CRPHLF.
Statistical analysis
The data analysis was performed using IBM SPSS Statistics 
ver. 22 (SPSS Inc., Chicago, IL, USA). Categorical variables are 
expressed as frequency (%), whereas continuous variables 
are presented as mean with range or ± standard deviation. 
The association between variables and PHLF was tested as 
continued and categorical using logistic regression analysis and 
Fisher exact test, respectively. The optimal cutoff values for RLV/
TFLV ratio, RLV/BW ratio, liver stiffness, ICG R15, and platelet 
count were determined using receiver operating characteristic 
(ROC) curve analysis. Statistically significant variables (P < 0.05) 
on univariate analysis were entered into a multivariate logistic 
regression model to identify the independent risk factors 
for CRPHLF. Two-sided P-values < 0.05 were used to define 
statistical significance.
RESULTS
Patient characteristics of the primary and validation 
cohorts
A total of 90 patients who met the inclusion criteria were 
included in the analysis in the primary cohort, comprising 12 


















































0.2 0.4 0.6 0.8
Platelet count (P < 0.001)
RLV/BW ratio (P < 0.001)
RLV/TFLV ratio (P = 0.002)
Reference line
Source of the curve
Liver stiffness (kPa) (P = 0.050)
ICG R15 (%) (P = 0.294)
Reference line
Source of the curve
RLV/TFLV ratio ( 0.018)
RLV/BW ratio ( 0.001)




Source of the curve
A B
C
Fig. 1. Receiver operating characteristic curve of clinically relevant posthepatectomy liver failure (International Study Group 
of Liver Surgery grades B and C). (A) At a cutoff value of <140 (109/L), platelet count had a sensitivity of 86.7%, and specificity 
of 74.7% for predicting clinically relevant posthepatectomy liver failure. The optimal cutoff value for remnant liver volume-to-
body weight (RLV/BW) ratio was 0.55 (sensitivity, 80%; specificity, 73.3%), while remnant liver volume/total functional liver 
volume (RLV/TFLV) ratio was 35 (sensitivity, 80%; specificity, 57.3%) of the primary cohort. (B) Optimal value of liver stiffness 
is 11.1 kPa (sensitivity, 66.7%; specificity, 57.3%), while indocyanine green retention rate at 15 minutes has an optimal cutoff 
value of 11.1 (sensitivity, 26.7%; specificity, 76%) of the primary cohort. (C) In the validation cohort, the optimal cutoff values 
for platelet count, RLV/BW ratio, and RLV/TFLV ratio were the same as the primary cohort.
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(26.6%) who experienced PHLF according to the ISGLS criteria. 
Among them, 15 (16.7%) had CRPHLF (11 grade B and 4 grade C 
PHLF).
Among 4 patients with grade C PHLF, 3 died postoperatively. 
These patients were managed in the intensive care unit. Three 
required invasive mechanical ventilation. Hemodialysis was 
performed in 2 patients. Patients with grade B PHLF (n = 9) 
were managed conservatively in the intermediate care unit 
through administrations of FFP, albumin, and diuretics if 
appropriate. All patients with grade B recovered well. However, 
the average length of hospital stay among patients with CRPHLF 
was 23.7 ± 14.3 days.
For the validation cohort, 97 patients were included. Notably, 
there were more patients with liver cirrhosis in the primary 
cohort compared to the validation cohort (73.3% vs. 38.1%, P < 
0.001, respectively). Table 1 summarizes the clinicopathological 
characteristics of the patients who underwent right 
hepatectomy for HCC in the primary and validation cohorts.
Analysis of factors predicting CRPHLF
In the primary cohort, we compared the preoperative clinical 
variables associated with no CRPHLF and CRPHLF (Table 2). 
Platelet count (P < 0.001), liver stiffness (P = 0.025), RLV/
TFLV ratio (P = 0003), and RLV/BW ratio (P < 0.001) were 
significantly associated with CRPHLF.
To determine optimal cutoff values for each variable, an 
ROC curve analysis was performed (Fig. 1A). In the primary 
cohort, the optimal cutoff values for platelet, RLV/BW ratio, 
RLV/TFLV ratio, liver stiffness, and ICG R15 were 140 (109/
L), 0.55, 35%, 11 kPa, and 11%, respectively. Platelet count had 
the widest area under the curve (AUC, 0.796; 95% confidence 
interval [CI], 0.689–0.902, P < 0.001). The RVL/BW ratio had a 
wider AUC (0.793, 95% CI, 0.641–0.877; P < 0.001) compared 
to RLV/TFLV ratio (0.759; 95% CI, 0.352–0.679; P = 0.002). This 
result was also confirmed by the validation cohort with AUC 
values of 813 (95% CI, 0.701–0.925; P < 0.001), 0.742 (95% CI, 
0.632–0.851; P < 0.001), and 0.676 (0.530–0.822; P = 0.018) for 
platelet count, RLV/BW, and RLV/TFLV ratio, respectively (Fig. 
1B). Liver stiffness and ICG 15R had AUC values of, 0.661 (95% 
CI, 0.524–0.798; P = 0.050), and 0.586 (95% CI, 438–0.735; P = 
0.294), respectively.
A univariate logistic regression analysis was performed for 
each optimal cutoff value. A platelet count <140 (109/L), liver 
stiffness at kPA > 11, RLV/TFLV ratio of <35%, and RLV/BW 
ratio of <0.55 were significantly associated with CRPHLF (P < 
0.05). On multivariate analysis, only a platelet count <140 (109/L) 
(hazard ratio [HR], 24.231; 95% CI, 3.623–161.693; P = 0.001) and 
RVL/BW ratio < 0.55 (HR, 25.600; 95% CI, 4.185–156.590; P < 
0.001) were independently associated with CRPHLF. Since RLV/
BW ratio had higher AUC compared to RLV/FTLV ratio, the RLV/
BW was the variable selected to be entered in the multivariable 
analysis model (Table 3).
Consequently, we identified 3 risk subsets for predicting 
CRPHLF after right hepatectomy in the primary cohort (low, 
intermediate, high risk). Among the 12 patients who had both a 
platelet count <140 (109/L) and RLV/BW ratio < 0.55 (high-risk 
group), 9 (75%) had CRPHLF. Likewise, 5 of 38 patients (13.2%) 
with either of the risk factors (intermediate-risk group) had 
CRPHLF, while 1 of 40 patients (2.5%) had no risk factors (low-
risk group). These results were confirmed by the validation 
cohort (Fig. 2). Using the same cut off values for platelet count 
and RLV/BW ratio, 10 out of 13 high-risk patients (76.9%) had 
CRPHLF. In addition, 8 out of 39 patients (20.5%) and 1 out of 44 
patients (2.2%) had CRPHLF in the intermediate- and low-risk 
groups, respectively.
A subgroup analysis combining the primary and validation 
cohort was made among patients with no liver cirrhosis and 
with liver cirrhosis. Among 187 patients, 84 (44.9%) had liver 
cirrhosis while 103 (55.1%) had no liver cirrhosis. Compared 
to the RLV/BW ratio, the RLV/TLFV ratio had a smaller AUC in 
patients with liver cirrhosis and no liver cirrhosis (AUC, 0.762; 
95% CI, 0.649–0.874; P < 0.001 vs. AUC, 0.785; 95% CI, 0.694–




P-value HR 95% CI P-value HR 95% CI
Platelet count (109/L) < 140 <0.001 19.158 3.958–92.734 0.001 24.231 3.623–161.693
Liver stiffness on FibroScan (kPa) > 11 0.038 3.695 1.077–12.674 0.184 3.310 0.566–19.359
RLV/TFLV (%) < 35a) 0.001 9.043 2.328–35.130 - - -
RLV/BW < 0.55 (%) <0.001 11.000 2.810–43.062 <0.001 25.600 4.185–156.590
ICG 15 (%) > 11 0.220 2.161 0.630–7.406 - - -
HR, hazard ratio; CI, confidence interval; RLV, remnant liver volume; TFLV, total functional liver volume; BW, body weight; ICG R15, 
indocyanine green retention rate at 15 minutes.
a)Not included in multivariate analysis.
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0.876; P < 0.001; and, AUC, 0.626; 95% CI, 0.438–0.814; P = 0.164 
vs. AUC, 0.748; 95% CI, 0.611–0.855; P=0.007, respectively). The 
platelet count had the highest AUC among the 3 parameters in 
patients with liver cirrhosis (AUC, 0.794; 95% CI, 0.693–0.896; P 
< 0.001) and no liver cirrhosis (AUC, 0.814; 95% CI, 0.683–0.944; 
P = 0.001). The optimal cutoff value of the RLV/BW ratio and 
RLV/TFLV ratio for predicting CRPHLF among patients with 
liver cirrhosis and no liver cirrhosis where the same as the 
results of the primary cohort (0.55 and 35%, respectively). 
However, platelet count had a lower cutoff value in patients 
with liver cirrhosis compared to patients with no liver cirrhosis 
(138 [109/L] and 140 [109/L], respectively). Nevertheless, among 
84 patients with no liver cirrhosis, 6 out of 8 high-risk patients 
(75%) (platelet count < 140 [109/L] and RLV/BW ratio < 0.55) 
had CLPHLF while 1 out of 40 low-risk patients (2.5%) (platelet 
count > 140 [109/L] and RLV/BW ratio > 0.55) had a CRPHLF. 
Likewise, among 103 patients with liver cirrhosis, 13 out of 17 
patients (76.5%) had CLPHLF while 1 out of 45 low-risk patients 












































Fig. 2. Percentage risk of patients with hepatocellular carcinoma who underwent right hepatectomy according to the number 
of risk factors (platelet count < 140 [109/L] and remnant liver volume-to-body weight ratio < 0.55). (A) Primary cohort and (B) 
validation cohort. High risk, platelet count < 140 (109/L), and RLV/BW ratio < 0.55; intermediate risk, either platelet count 
< 140 (109/L) or RLV/BW ratio < 0.55; low risk, platelet count > 140 (109/L) and RLV/BW ratio > 0.55. CRPHLF, clinically 












































Fig. 3. Percentage risk of patients with hepatocellular carcinoma who underwent right hepatectomy according to the (platelet 
count < 140 [109/L] and remnant liver volume-to-body weight ratio < 0.55). (A) Patients with liver cirrhosis and (B) patients 
with no liver cirrhosis. High risk, platelet count < 140 (109/L) and RLV/BW ratio < 0.55; intermediate risk, either platelet count 
< 140 (109/L) or RLV/BW ratio < 0.55; low risk, platelet count > 140 (109/L) and RLV/BW ratio > 0.55. CRPHLF, clinically 
relevant posthepatectomy liver failure; RLV/BW, remnant liver volume-to-body weight.
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DISCUSSION
It is well recognized that FLR is the most reliable determinant 
of hepatic dysfunction after major hepatectomy [16,17]. The FLR 
is usually expressed as the RLV/TLV ratio [18]. Truant et al. [7] 
reported that RLV/BW ratio was more specific than RLV/TLV in 
predicting liver failure after extended hepatectomy. At a cutoff 
value of 0.50%, RLV/BW ratio was associated with significantly 
higher 3-month morbidity and mortality rates as well as PHLF-
associated mortality. The same cutoff value that was used by 
Schnitzbauer et al. [19] to classify patients undergoing portal 
vein ligation and in situ splitting achieved adequate FLR. 
Nonetheless, the present study demonstrated that RLV/BW ratio 
was independently associated with CRPHLF at a cutoff value of 
<0.55%. Although RLV/TFLV ratio was associated with CRPHLF 
at a cutoff value of 35%, it was shown in this cohort that RLV/
BW ratio was more sensitive and specific than RLV/BW ratio for 
predicting CRPHLF.
Although a CT volumetric study preoperatively assesses FLR, 
it does not determine the associated liver disease or functional 
liver derangement. In the present study, we carefully evaluated 
liver function using child and model for end-stage liver disease 
(MELD) scores and properly selected patients to undergo liver 
resection. Hence, all of our patients had a Child class of A and 
a mean MELD score of 6.8 ± 0.89. However, in this present 
cohort, ICG R15 was not entirely adopted in our institution 
to assess liver function. As such, only in selected patients 
the ICG R15 was performed. The cutoff value of ICG R15 for 
major hepatectomy for HCC was reportedly safe at <10% [20]. 
Although reports of the safety of major hepatectomy used an 
ICG R15 cutoff value of <14% [21], our study found that ICG R15 
as a continuous and categorical variable with an optimal cutoff 
value of 11% was not significantly associated with CRPHLF.
Furthermore, the use of transient elastography to evaluate 
the underlying liver fibrosis or cirrhosis was also not well 
adopted during this period in our institution; hence, it was 
not performed in all patients. Our present study showed a 
significant association between liver stiffness and CRPHLF 
at a cutoff value of 11 kPa on univariate analysis. Although 
it was reported that liver stiffness is a good determinant for 
liver cirrhosis [22,23], it was not found to be an independent 
predictor of CRPHLF.
As an indirect determinant for portal hypertension, low 
platelet count is known to be associated with liver dysfunction 
following major hepatectomy [12,24]. Although the optimal 
cutoff value for platelet count to predict PHLF varies among 
studies [25], here we found that a platelet count < 140 (109/L) 
was a significant independent predictor for CRPHLF.
However, it is noteworthy that the ability of the FLR to 
sustain the body’s metabolic demand after hepatectomy not 
only depends on its functional reserve but also on its re-
generative capacity. Notwithstanding that liver regenerative 
capacity is influenced by underlying diseases, in particular the 
presence of cirrhosis, the effect of low platelet count on liver 
regeneration has also been established in several studies. As 
such, low platelet count, as a surrogate for portal hypertension, 
may also influence the development of CRPHLF through 
its negative effect of liver regenerative capacity following 
hepatectomy.
Interestingly, we found that the presence of both an RLV/
BW ratio < 0.55% and a platelet count < 140 (109/L) was 
associated with a 75% risk of CRPHLF after right hepatectomy. 
Nevertheless, if one of these parameters is present, only 13.2% 
are at risk of CRPHLF. Most importantly, if none of these are 
present, there is a 2.5% risk of CRPHLF. As such, when planning 
for right hepatectomy for HCC, it should be emphasized that 
patients with these 2 risk factors may benefit from PVE or 
volume-preserving right hepatectomy. In particular, the ventral 
segment-preserving right hepatectomy was found to be very 
useful for patients with small left liver volume. This procedure 
could preserve an adequate remnant liver volume to sustain the 
patient’s metabolic demand [26]. However, for patients in the 
low-risk group, a right hepatectomy can be performed.
The present study was a retrospective design, which creates 
an unavoidable limitation. First, the accuracy of the CT 
volumetry software (Voxelplus) was not fully evaluated, mainly 
because of the retrospective nature of the study. Although 
our previous data showed a small discrepancy between 
preoperative CT liver volume and the actual specimen weight 
(714.9 ± 251.21 vs. 711.9 ± 252.45, respectively) [26], the actual 
weights, however, were based on the pathologic report which 
could to lead overestimation or underestimation of the result 
[27]. We believe that to fully assess its predictive value for the 
actual resected specimen, a well-design study is needed; such 
as a timely specimen-weight assessment right after resection 
– a scenario which can possibly be attained during living 
donor liver transplantation [28]. Secondly, it was also a single-
institution study with a relatively small sample. Nevertheless, 
to the best of our knowledge, this is the first study which 
included the data on preoperative CT volumetry studies (RLV/
BW and RLV/TFLV), ICG R 15%, liver stiffness, and traditional 
laboratory values such as platelet count for predicting CRPHLF. 
Furthermore, we validated our results. Although there was a 
significant difference in terms of the number of patients with 
liver cirrhosis between the 2 groups, and this maybe the reason 
why the ICG R15 or Fibroscan was requested on this group 
of patients, this difference may further expand the clinical 
application of this finding in noncirrhotic and cirrhotic patients. 
In fact, a subgroup analysis showed the same results as the 
primary and validation cohort. In clinical practice, utilizing 
RLV/BW ratio and platelet count can provide simple and useful 
information regarding decision-making and risk-stratification 
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strategies for managing hepatocellular cancer, especially in 
centers where sophisticated parameters such as ICG R15 or 
liver stiffness measurement are not available. It is very easy to 
perform and provides a reliable cutoff value that could prevent 
PHLF. Although the emerging role of new modalities such as 
99mTc-mebrofenin hepatobiliary scintigraphy [29] and gadoxetic 
acid-enhanced MRI [30] in predicting PHLF has been reported 
in the literature, its propagation is still limited only to selected 
centers. However, a larger prospective or multicenter study is 
required to validate our findings.
In summary, RLV/BW ratio of <0.55 and platelet count < 140 
(109/L) are the only independent predictors of CRPHLF after 
right hepatectomy in Child A patients in this cohort. CRPHLF 
will develop in 75% of patients with 2 of these risk factors, and 
in 2.5% of patients with none of these risk factors. High-risk 
patients may benefit from preoperative PVE and parenchymal 
preserving right hepatectomy, while low-risk patients may 
undergo right hepatectomy. Caution should be observed in 
doing right hepatectomy on intermediate-risk patients due to 
the associated 13.2% risk of CRPHLF. However, these findings 
should be validated in a prospective and a well-designed 
randomized study.
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